Alkem Laboratories Earnings/Conference Calls

Alkem Laboratories earnings concalls and investor presentations

Load latest

Alkem Laboratories Ltd.

09 Feb 2024

5521.00

-1.91%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q3FY24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php. Kindly take the same on records.

pdf

Alkem Laboratories Ltd.

09 Feb 2024

5521.00

-1.91%

Investor Presentation

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find enclosed herewith press release and analyst presentation on Q3FY24 and 9MFY24 earnings and business updates. Kindly take a note of the same.

pdf

Alkem Laboratories Ltd.

10 Nov 2023

5521.00

-1.91%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith the transcript of the ''Q2 FY2024 Earnings Conference Call'' which was hosted by the Company on Tuesday 07th November, 2023. The said transcript shall also be made available on the website of the Company.

pdf

Alkem Laboratories Ltd.

08 Nov 2023

5521.00

-1.91%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q2FY24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php.

pdf

Alkem Laboratories Ltd.

07 Nov 2023

5521.00

-1.91%

Alkem Laboratories Results Earnings Call for Q2FY24

Conference Call with Alkem Laboratories Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Alkem Laboratories Ltd.

07 Nov 2023

5521.00

-1.91%

Investor Presentation

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find enclosed press release and analyst presentation on Q2FY24 earnings and business updates and the same shall be uploaded on website of the Company

pdf

Alkem Laboratories Ltd.

14 Aug 2023

5521.00

-1.91%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find attached herewith the transcript of the "Q1 FY 2024 Earnings Conference Call" which was hosted by the Company on Thursday, 10th August, 2023. The said transcript shall also be made available on the website of the Company. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

10 Aug 2023

5521.00

-1.91%

Earnings Call

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the 'Q1FY24 Earnings Conference Call' is available on the website of the Company at https://www.alkemlabs.com/earnings-call.php. Kindly take the same on records.

pdf

Alkem Laboratories Ltd.

10 Aug 2023

5521.00

-1.91%

Alkem Laboratories Results Earnings Call for Q1FY24

Conference Call with Alkem Laboratories Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Alkem Laboratories Ltd.

10 Aug 2023

5521.00

-1.91%

Investor Presentation

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

With reference to relevant provisions of SEBI LODR Reg, 2015 we enclose herewith press release and analyst presentation on Q1FY24 earnings and business updates and the same shall be uploaded on the website of the Company.

pdf

Is Alkem Laboratories Ltd. worth buying?

140 Votes:

Buy 79.29%

Sell 14.29%

Hold 6.43%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf